926
|
Zhu X, Wang Y, Ogawa O, Lee HG, Raina AK, Fujioka H, Shimohama S, Atwood CS, Petersen RB, Perry G, Smith MA. Oral Presentations OP01: Neurodegenerative Diseases. J Neurochem 2008. [DOI: 10.1046/j.1471-4159.81.s1.44_1.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
927
|
Hernandez BY, Wilkens LR, Zhu X, McDuffie K, Thompson P, Shvetsov YB, Ning L, Goodman MT. Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis 2008; 197:787-94. [PMID: 18284369 DOI: 10.1086/528379] [Citation(s) in RCA: 92] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
BACKGROUND Lack of circumcision has been identified as a risk factor for male genital human papillomavirus (HPV) infection, although this association has not been consistently supported. METHODS Specimens for HPV testing were collected from a cohort of 379 (primarily heterosexual) adult males. HPV prevalence in the glans penis and coronal sulcus, penile shaft, scrotum, semen, and urine was compared by circumcision status. RESULTS Overall, HPV DNA prevalence ranged from 6% in semen to 52% in the penile shaft. The prevalence of any HPV infection in the glans/corona was significantly higher in uncircumcised men (46%) than in circumcised men (29%) (odds ratio [OR], 1.96 [95% confidence interval (CI), 1.02-3.75], adjusted for demographic characteristics and sexual history). Uncircumcised men also had an increased risk of oncogenic HPV infection (adjusted OR, 2.51 [95% CI, 1.11-5.69]) and infection with multiple HPV types (adjusted OR, 3.56 [95% CI, 1.50-8.50]). Among uncircumcised men, HPV prevalence in the foreskin (44%) was comparable to that in the glans/corona, and type-specific positivity was observed between the 2 sites (kappa=0.52). CONCLUSIONS Uncircumcised men have an increased risk of HPV infection, including with oncogenic HPV, specifically localized to the glans/corona, possibly because of its proximity to the foreskin, which may be particularly vulnerable to infection.
Collapse
|
928
|
Gillin M, Zhu X, Sahoo N, Lii M, Arjomandy B. TH-D-350-01: Time and Manpower Requirements for Clinical Commissioning of the Passively Scattered Proton Beams at PTC-H. Med Phys 2008. [DOI: 10.1118/1.2962886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
929
|
Li H, Sahoo N, Dong L, Gillin M, Mohan R, Zhu X. SU-GG-J-63: CT Artifacts of High-Density Materials in Proton Radiation Therapy. Med Phys 2008. [DOI: 10.1118/1.2961613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
930
|
Gillin M, Zhu X, Sahoo N, Bues M, Ciangaru G, Arjomandy B, Poenisch F. SU-GG-T-89: Dosimetry Characteristics of the Discrete Spot Scanning Proton Beam at PTCH. Med Phys 2008. [DOI: 10.1118/1.2961841] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
931
|
Ciangaru G, Sahoo N, Arjomandy B, Zhu X, Gillin M. SU-GG-T-250: Effect of Titanium Implants On Therapeutic Proton Dose Delivered to Patients. Med Phys 2008. [DOI: 10.1118/1.2962002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
932
|
Li H, Liu R, Wu R, Sahoo N, Mohan R, Gillin M, Zhu X. WE-E-AUD C-04: Effect of CT Calibration Phantom Size On the Range in Proton Radiation Therapy. Med Phys 2008. [DOI: 10.1118/1.2962785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
933
|
Lindsay P, Yildirim G, Garden A, Zhang L, Yu Z, Zhang Y, Zhu X, Theriot L, Ahamad A, Dong L. SU-GG-T-50: Dosimetric Impact of Anatomy Variations and Benefits of Mid-Course Replanning for Head and Neck IMRT. Med Phys 2008. [DOI: 10.1118/1.2961800] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
934
|
Ding X, Sahoo N, Zhu X, Yang J, Arjomandy B, Lii M, Titt U, Mohan R, Smith A, Gillin M. SU-GG-T-321: Validation Study of the GEANT 4 Monte-Carlo Simulation of the Proton Dose Distribution From Passively Scattered Proton Beam Nozzles at the Proton Therapy Center at Houston. Med Phys 2008. [DOI: 10.1118/1.2962073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
935
|
Yang M, Virshup G, Mohan R, Shaw C, Zhu X, Dong L. TH-C-350-10: Improving Accuracy of Electron Density Measurement in the Presence of Metallic Implants Using Orthovoltage Computed Tomography. Med Phys 2008. [DOI: 10.1118/1.2962835] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
936
|
Giebeler A, Fontenot J, Balter P, Ciangaru G, Zhu X, Newhauser W. TU-C-AUD B-04: Dose Perturbations Caused by Implanted Helical Gold Markers Used in Patients Receiving Proton Radiation Therapy for Prostate Cancer. Med Phys 2008. [DOI: 10.1118/1.2962440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
937
|
Arjomandy B, Sahoo N, Zhu X, Zullo J, Wu R, Zhu M, Ding X, Gillin M. TH-D-352-06: An Overview of Comprehensive Proton Machine Quality Assurance at the University of Texas M.D. Anderson Cancer Center. Med Phys 2008. [DOI: 10.1118/1.2962949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
938
|
Wu R, Amos R, Sahoo N, Kornguth D, Bluett J, Gillin M, Zhu X. SU-GG-J-80: Effect of CT Truncation Artifacts to Proton Dose Calculation. Med Phys 2008. [DOI: 10.1118/1.2961630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
939
|
Barot K, Wu S, Zhu X. Risk of renal dysfunction with zoledronic acid in patients with metastatic solid tumors. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.20530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
940
|
Hou Y, Zhu X, Lu S, Zhou Y, Xu J, Ji Y, Hou J, Qi W, Shi Y, Tan Y. Study on malignancy, staging, and grading for gastrointestinal stromal tumors. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.21521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
941
|
Wang L, Zhao L, Ji W, Wang X, Zhu X, Hayman JA, Kalemkerian GP, Brenner D, Lawrence TS, Kong F. Combining plasma TGF-β1 and lung dosimetric factor to predict radiation-induced lung toxicity in patients with non-small cell lung cancer: A combined analysis from Beijing and Michigan. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.7548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
942
|
Nunomura A, Moreira PI, Lee HG, Zhu X, Castellani RJ, Smith MA, Perry G. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS 2008; 6:411-23. [PMID: 18220780 DOI: 10.2174/187152707783399201] [Citation(s) in RCA: 102] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Neuronal death is a common feature in neurodegenerative diseases including Alzheimer disease (AD) and Parkinson disease (PD). This occurs over years, not the minutes of classically defined apoptosis, and neurons show both responses of apoptosis and regeneration, evidenced by accumulated oxidative insult and attempts at cell cycle re-entry. There is recent evidence suggesting that several known gene mutations in causing familial AD (amyloid beta protein precursor, presenilin-1, or presenilin-2 gene) and familial PD (Parkin, PINK-1, or DJ-1 gene) are associated with increased oxidative stress. Also, several known genetic (e.g. Apolipoprotein Eepsilon4 variant) and environmental (e.g. metals or pesticides exposure) risk factors of sporadic AD and/or PD are associated with increased oxidative stress. In concord, patients at the preclinical stages of AD and PD as well as cellular and animal models of the diseases provide consistent evidence that oxidative insult is a significant early event in the pathological cascade of AD and PD. In contrast to the general aspects of the pathological hallmarks, aggregation of the disease-specific proteins such as amyloid-beta, tau, and alpha-synuclein may act as a compensatory (survival) response against the oxidative insult via the mechanism that the disease-specific structures sequester redox-active metals. Expanding knowledge of the molecular mechanisms of organism longevity indicates that pro-longevity gene products such as forkhead transcription factors and sirtuins are involved in the insulin-like signaling pathway and oxidative stress resistance against aging. An enhancement of the pro-longevity signaling (e.g. caloric restriction) may be a promising approach as anti-oxidative strategy against age-associated neurodegenerative diseases.
Collapse
|
943
|
Zhu X, Schülzgen A, Li H, Li L, Wang Q, Suzuki S, Temyanko VL, Moloney JV, Peyghambarian N. Single-transverse-mode output from a fiber laser based on multimode interference. OPTICS LETTERS 2008; 33:908-910. [PMID: 18451935 DOI: 10.1364/ol.33.000908] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
An alternative original approach to achieve single-transverse-mode laser emissions from multimode (MM) active fibers is demonstrated. The fiber cavity is constructed by simply splicing a conventional passive single-mode fiber (SMF-28) onto a few centimeters-long active MM fiber section whose length is precisely controlled. Owing to the self-imaging property of multimode interference (MMI) in the MM fiber, diffraction-limited laser output is obtained from the end of the SMF-28, and the MMI fiber laser is nearly as efficient as the corresponding MM fiber laser. Moreover, because of the spectral filtering effect during in-phase MMI, the bandwidth of the MMI fiber laser is below 0.5 nm.
Collapse
|
944
|
Zhu X, Clackdoyle R, Shortkroff S, Yanch J. In vivo prompt gamma neutron activation analysis for the screening of boron-10 distribution in a rabbit knee: a simulation study. Phys Med Biol 2008; 53:2715-32. [PMID: 18445874 DOI: 10.1088/0031-9155/53/10/018] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Boron neutron capture synovectomy (BNCS) is under development as a potential treatment modality for rheumatoid arthritis (RA). RA is characterized by the inflammation of the synovium (the membrane lining articular joints), which leads to pain and a restricted range of motion. BNCS is a two-part procedure involving the injection of a boronated compound directly into the diseased joint followed by irradiation with a low-energy neutron beam. The neutron capture reactions taking place in the synovium deliver a local, high-linear energy transfer (LET) dose aimed at destroying the inflamed synovial membrane. For successful treatment via BNCS, a boron-labeled compound exhibiting both high synovial uptake and long retention time is necessary. Currently, the in vivo uptake behavior of potentially useful boronated compounds is evaluated in the knee joints of rabbits in which arthritis has been induced. This strategy involves the sacrifice and dissection of a large number of animals. An in vivo (10)B screening approach is therefore under investigation with the goal of significantly reducing the number of animals needed for compound evaluation via dissection studies. The 'in vivo prompt gamma neutron activation analysis' (IVPGNAA) approach uses a narrow neutron beam to irradiate the knee from several angular positions following the intra-articular injection of a boronated compound whose uptake characteristics are unknown. A high-purity germanium detector collects the 478 keV gamma photons produced by the (10)B capture reactions. The (10)B distribution in the knee is then reconstructed by solving a system of simultaneous equations using a weighted least squares algorithm. To study the practical feasibility of IVPGNAA, simulation data were generated with the Monte Carlo N-particle transport code. The boron-containing region of a rabbit knee was partitioned into 8 compartments, and the (10)B prompt gamma signals were tallied from 16 angular positions. Results demonstrate that for this level of spatial resolution, an estimate of (10)B distribution inside the joint can be obtained to within 10% uncertainty, under ideal conditions. Variations of the anatomic dimensions among individual rabbit knees and potential knee positioning errors will result in an uncertainty of over 20%. IVPGNAA thus provides sufficient resolution and quantification regarding the in vivo uptake characteristics of boronated pharmaceuticals to serve as a useful means of screening new compounds of potential use in BNCS.
Collapse
|
945
|
Wang B, Li J, Qiao C, Chen C, Hu P, Zhu X, Zhou L, Bogan J, Kornegay J, Xiao X. A canine minidystrophin is functional and therapeutic in mdx mice. Gene Ther 2008; 15:1099-106. [PMID: 18432277 DOI: 10.1038/gt.2008.70] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Duchenne muscular dystrophy (DMD) is the most common and lethal genetic muscle disorder lacking a curative treatment. We wish to use the dystrophin-deficient golden retriever muscular dystrophy (GRMD) dog, a canine model of DMD, to investigate adeno-associated virus (AAV) vector-mediated minidystrophin gene therapy. The dog model is useful in evaluating vector dose requirement and immunological consequences owing to its large size and outbred nature. In this study, we have cloned and constructed a canine minidystrophin gene vector. Owing to limited availability of the GRMD dogs, here we first examined the functions and therapeutic effects of the canine minidystrophin in the mdx mouse model. We observed efficient minigene expression without cellular immune responses in mdx mice after AAV1-cMinidys vector intramuscular injection. We also observed restoration of the missing dystrophin-associated protein complex (DPC) onto the sarcolemma, including sarcoglycans and dystrobrevin, and a partial restoration of alpha-syntrophin and neural nitric oxide synthase (nNOS). In addition, minidystrophin treatment ameliorated dystrophic pathology, such as fibrosis and myofiber central nucleation (CN). CN remained minimal (<2%) after AAV injection in the neonatal mdx mice and was reduced from more than 75% to about 25% after AAV injection in adult mdx mice. Finally, in vivo cell membrane leakage test with Evans blue dye showed that the canine minidystrophin could effectively protect the myofiber plasma membrane integrity. Our results, thus, demonstrated the functionality and therapeutic potential of the canine minidystrophin and paved its way for further testing in the GRMD dog model.
Collapse
|
946
|
Zhu X, Xu N, Zhuang P. Effect of partonic "wind" on charm quark correlations in high-energy nuclear collisions. PHYSICAL REVIEW LETTERS 2008; 100:152301. [PMID: 18518098 DOI: 10.1103/physrevlett.100.152301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/03/2007] [Indexed: 05/26/2023]
Abstract
In high-energy collisions, massive heavy quarks are produced back to back initially and they are sensitive to early dynamical conditions. The strong collective partonic wind from the fast expanding quark-gluon plasma created in high-energy nuclear collisions modifies the correlation pattern significantly. While the hot and dense medium in collisions at the BNL Relativistic Heavy Ion Collider (sqrt[_s{NN}]=200 GeV) can only smear the initial back-to-back D_D correlation, a clear and strong near side D_D correlation is expected at the CERN Large Hadron Collider (sqrt[_s{NN}]=5500 GeV). This is considered as a signature for the strongly coupled quark-gluon plasma.
Collapse
|
947
|
Abstract
BACKGROUND Conventional treatment for primary dysmenorrhoea has a failure rate of 20% to 25% and may be contraindicated or not tolerated by some women. Chinese herbal medicine may be a suitable alternative. OBJECTIVES To determine the efficacy and safety of Chinese herbal medicine for primary dysmenorrhoea when compared with placebo, no treatment, and other treatment. SEARCH STRATEGY The Cochrane Menstrual Disorders and Subfertility Group Trials Register (to 2006), MEDLINE (1950 to January 2007), EMBASE (1980 to January 2007), CINAHL (1982 to January 2007), AMED (1985 to January 2007), CENTRAL (The Cochrane Library issue 4, 2006), China National Knowledge Infrastructure (CNKI, 1990 to January 2007), Traditional Chinese Medicine Database System (TCMDS, 1990 to December 2006), and the Chinese BioMedicine Database (CBM, 1990 to December 2006) were searched. Citation lists of included trials were also reviewed. SELECTION CRITERIA Any randomised controlled trials involving Chinese herbal medicine versus placebo, no treatment, conventional therapy, heat compression, another type of Chinese herbal medicine, acupuncture or massage. Exclusion criteria were identifiable pelvic pathology and dysmenorrhoea resulting from the use of an intra-uterine contraceptive device. DATA COLLECTION AND ANALYSIS Quality assessment, data extraction and data translation were performed independently by two review authors. Attempts were made to contact study authors for additional information and data. Data were combined for meta-analysis using either Peto odds ratios or relative risk (RR) for dichotomous data or weighted mean difference for continuous data. A fixed-effect statistical model was used, where suitable. If data were not suitable for meta-analysis, any available data from the trial were extracted and presented as descriptive data. MAIN RESULTS Thirty-nine randomised controlled trials involving a total of 3475 women were included in the review. A number of the trials were of small sample size and poor methodological quality. Results for Chinese herbal medicine compared to placebo were unclear as data could not be combined (3 RCTs). Chinese herbal medicine resulted in significant improvements in pain relief (14 RCTs; RR 1.99, 95% CI 1.52 to 2.60), overall symptoms (6 RCTs; RR 2.17, 95% CI 1.73 to 2.73) and use of additional medication (2 RCTs; RR 1.58, 95% CI 1.30 to 1.93) when compared to use of pharmaceutical drugs. Self-designed Chinese herbal formulae resulted in significant improvements in pain relief (18 RCTs; RR 2.06, 95% CI 1.80 to 2.36), overall symptoms (14 RCTs; RR 1.99, 95% CI 1.65 to 2.40) and use of additional medication (5 RCTs; RR 1.58, 95% CI 1.34 to 1.87) after up to three months of follow-up when compared to commonly used Chinese herbal health products. Chinese herbal medicine also resulted in better pain relief than acupuncture (2 RCTs; RR 1.75, 95% CI 1.09 to 2.82) and heat compression (1 RCT; RR 2.08, 95% CI 2.06 to 499.18). AUTHORS' CONCLUSIONS The review found promising evidence supporting the use of Chinese herbal medicine for primary dysmenorrhoea; however, results are limited by the poor methodological quality of the included trials.
Collapse
|
948
|
Mandalakas AM, Hesseling AC, Chegou NN, Kirchner HL, Zhu X, Marais BJ, Black GF, Beyers N, Walzl G. High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 2008; 12:417-423. [PMID: 18371268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023] Open
Abstract
SETTING Tygerberg district, Western Cape Province, South Africa. OBJECTIVE To measure the agreement of two interferon-gamma release assays (IGRAs) and the tuberculin skin test (TST) for the detection of Mycobacterium tuberculosis infection in human immunodeficiency virus (HIV) infected adults and children in a setting highly endemic for tuberculosis (TB). DESIGN Cross-sectional study. RESULTS In HIV-infected adults (n=20) and children (n=23), tests yielded discordant results, with 61% of individuals testing positive with T-SPOT.TB, 41% with TST and 28% with QuantiFERON TB Gold (QTF). In children, there was poor agreement between the TST and T-SPOT.TB (kappa [kappa]=-0.02), but moderate agreement between the TST and QTF (kappa=0.44). In adults, there was moderate agreement between the TST and T-SPOT.TB (kappa=0.43), and the TST and QTF (kappa = 0.46). In children and adults, there was fair agreement between the T-SPOT.TB and QTF (kappa=0.33). Twenty per cent of adults had >or=1 indeterminate IGRA results. CONCLUSIONS There is poor to moderate agreement between the TST and IGRAs in HIV-infected adults and children. T-SPOT.TB may have improved sensitivity for detection of M. tuberculosis infection in HIV-infected individuals compared to the QTF and the TST. In HIV-infected individuals, IGRA test properties are affected by test cut-off point and nil control responses.
Collapse
|
949
|
Du L, Zhu X, Gerber R, Huffman J, Lou L, Jorgenson J, Yu F, Zaleta-Rivera K, Wang Q. Biosynthesis of sphinganine-analog mycotoxins. J Ind Microbiol Biotechnol 2008; 35:455-64. [PMID: 18214562 DOI: 10.1007/s10295-008-0316-y] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2007] [Accepted: 01/10/2008] [Indexed: 10/22/2022]
Abstract
Sphinganine-analog mycotoxins (SAMT) are polyketide-derived natural products produced by a number of plant pathogenic fungi and are among the most economically important mycotoxins. The toxins are structurally similar to sphinganine, a key intermediate in the biosynthesis of ceramides and sphingolipids, and competitive inhibitors for ceramide synthase. The inhibition of ceramide and sphingolipid biosynthesis is associated with several fatal diseases in domestic animals and esophageal cancer and neural tube defects in humans. SAMT contains a highly reduced, acyclic polyketide carbon backbone, which is assembled by a single module polyketide synthase. The biosynthesis of SAMT involves a unique polyketide chain-releasing mechanism, in which a pyridoxal 5'-phosphate-dependent enzyme catalyzes the termination, offloading and elongation of the polyketide chain. This leads to the introduction of a new carbon-carbon bond and an amino group to the polyketide chain. The mechanism is fundamentally different from the thioesterase/cyclase-catalyzed polyketide chain releasing found in bacterial and other fungal polyketide biosynthesis. Genetic data suggest that the ketosynthase domain of the polyketide synthase and the chain-releasing enzyme are important for controlling the final product structure. In addition, several post-polyketide modifications have to take place before SAMT become mature toxins.
Collapse
|
950
|
Zhao Y, Jiao J, Shan Z, Fan Q, Hu J, Zhang Q, Zhu X. Effective management of main bronchial rupture in patients with chest trauma. Thorac Cardiovasc Surg 2008; 55:447-9. [PMID: 17902068 DOI: 10.1055/s-2007-965378] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
BACKGROUND The purpose of the current study was to investigate the most effective diagnostic method and the effect of surgical treatment on traumatic main bronchial rupture. METHODS Chest X-rays, CT and fiberoptic bronchoscopy were the main means used to confirm the diagnosis. Surgery was performed as early as possible. RESULTS Pneumonectomy was performed in 1 patient. Bronchial end-to-end anastomosis was performed in 10 patients whose lungs were well ventilated, and lung function recovered. CONCLUSION Main bronchial rupture occurs relatively rarely. Early diagnosis and operative intervention can save lives.
Collapse
MESH Headings
- Anastomosis, Surgical
- Bronchi/injuries
- Bronchi/pathology
- Bronchi/physiopathology
- Bronchi/surgery
- Bronchoscopy/methods
- Early Diagnosis
- Female
- Fiber Optic Technology
- Humans
- Male
- Pneumonectomy
- Radiography, Thoracic
- Respiratory Function Tests
- Rupture
- Time Factors
- Tomography, X-Ray Computed
- Treatment Outcome
- Wounds, Nonpenetrating/diagnostic imaging
- Wounds, Nonpenetrating/pathology
- Wounds, Nonpenetrating/physiopathology
- Wounds, Nonpenetrating/surgery
- Wounds, Penetrating/diagnostic imaging
- Wounds, Penetrating/pathology
- Wounds, Penetrating/physiopathology
- Wounds, Penetrating/surgery
Collapse
|